150322-87-5

Basic information

• Product Name: 4,5,6,7-Tetrahydrofuro[3,2-c]pyridine
• Synonyms: 4,5,6,7-Tetrahydrofuro[3,2-c]pyridine
• CAS NO: 150322-87-5
• Molecular Formula: C7H9NO
• Molecular Weight: 123.15246
• Mol File: 150322-87-5.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 4,5,6,7-Tetrahydrofuro[3,2-c]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4,5,6,7-Tetrahydrofuro[3,2-c]pyridine(150322-87-5)
• EPA Substance Registry System: 4,5,6,7-Tetrahydrofuro[3,2-c]pyridine(150322-87-5)

Safety Data

• Hazardous Substances Data: 150322-87-5(Hazardous Substances Data)

Upstream product

• 179060-38-9 1-chloro-2-(benzyl-(furan-3-ylmethyl)amino)ethane 
• 179060-37-8 2-[benzyl(furan-3-ylmethyl)amino]ethan-1-ol 
• 179057-37-5 N-((furan-3-yl)methyl)(phenyl)methanamine 
• 498-60-2 furan-3-carboxaldehyde 
• 179060-39-0 5-benzyl-4H,5H,6H,7H-furo[3,2-c]pyridine 
• 1373492-28-4 C₇H₁₁NO₂ 
• 1121-46-6 2-Furan-2-yl-ethylamine 
• 699-18-3 2-(2-nitrovinyl)furan 
• 98-01-1 furfural 

Downstream Products

• 1373491-81-6 8-(2-chlorophenyl)-8-(6,7-dihydro-4H-furo[3,2-c]pyridin-5-yl)-2,2-dimethyloctanoic acid ethyl ester 
• 1373491-54-3 8-(2-chlorophenyl)-8-(6,7-dihydro-4H-furo[3,2-c]pyridin-5-yl)-2,2-dimethyloctanoic acid hydrochloride 
• 1373491-76-9 7-(2-chlorophenyl)-7-(6,7-dihydro-4H-furo[3,2-c]pyridin-5-yl)-2,2-dimethylheptanoic acid ethyl ester 
• 1373491-58-7 7-(2-chlorophenyl)-7-(6,7-dihydro-4H-furo[3,2-c]pyridin-5-yl)-2,2-dimethylheptanoic acid hydrochloride 
• 179060-34-5 tert-butyl 4H,5H,6H,7H-furo[3,2-c]pyridine-5-carboxylate 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS AND METHODS USEFUL FOR CHOLESTEROL MOBILISATION

The invention relates to classes of pharmaceutically-active heterocyclic compounds and pharmaceutically acceptable salts, and hydrates thereof, and compositions comprising the same. The invention also relates to methods for treating or preventing a disease or disorder, which comprises administering a therapeutically or prophylactically effective amount a compound described herein.

Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation

Compounds of formula (I): STR1 wherein: R1 is hydrogen, alkyl, halogen, haloalkyl, hydroxy, alkoxy, haloalkoxy, alkylthio, haloalkylthio, amino, alkanoyl, haloalkanoyl, carboxy, alkoxycarbonyl, carbamoyl, cyano, nitro, alkanesulfonyl, haloalkanesulfonyl or sulfamoyl; R2 is optionally substituted alkanoyl, optionally substituted alkenoyl, optionally substituted cycloalkylcarbonyl, substituted benzoyl, or 5,6-dihydro-1,4,2-dioxazin-3-yl; R3 is hydrogen, hydroxy, optionally substituted alkoxy, aralkyloxy, alkanoyloxy, alkenoyloxy, cycloalkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy, aralkyloxycarbonylxy, phthalidyloxy, (5-methyl-2-oxo-1,3-dioxolen-4-yl)methoxy, (5-phenyl-2-oxo-1,3-dioxolen-4-yl)methoxy, optionally substituted amino or nitro; Y is --NH-- or oxygen or sulfur; n is 1 to 5; and tautomers and salts of said compounds of formula (I), have the ability to inhibit blood platelet aggregation, and can thus be used for treatment and prophylaxis of thrombosis and embolisms.